Published in Curr Pharm Des on January 01, 2012
Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci (2015) 1.24
Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J Neurochem (2011) 1.21
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol (2011) 1.06
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proc Biol Sci (2016) 0.94
Corruption and spread of pathogenic proteins in neurodegenerative diseases. J Biol Chem (2012) 0.93
p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ (2016) 0.88
Alzheimer's disease: experimental models and reality. Acta Neuropathol (2016) 0.88
Cognitive and motor aging in female chimpanzees. Neurobiol Aging (2013) 0.86
Lessons from the analysis of nonhuman primates for understanding human aging and neurodegenerative diseases. Front Neurosci (2015) 0.85
The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin. Neurobiol Dis (2015) 0.81
Context dependence of protein misfolding and structural strains in neurodegenerative diseases. Biopolymers (2013) 0.80
Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis). Front Aging Neurosci (2014) 0.78
Infrastructure and resources for an aging population: embracing complexity in translational research. Transl Res (2013) 0.77
Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease. Neurobiol Aging (2016) 0.77
Analysis of synaptic gene expression in the neocortex of primates reveals evolutionary changes in glutamatergic neurotransmission. Cereb Cortex (2014) 0.77
Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX. Acta Neuropathol Commun (2016) 0.76
Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys). Comp Med (2013) 0.76
Contributions of Nonhuman Primates to Research on Aging. Vet Pathol (2016) 0.76
Age-related alterations of plasma glutathione and oxidation of redox potentials in chimpanzee (Pan troglodytes) and rhesus monkey (Macaca mulatta). Age (Dordr) (2014) 0.75
Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4. Am J Pathol (2017) 0.75
Amyloid-β oligomers unveil a novel primate model of sporadic Alzheimer's disease. Front Neurosci (2015) 0.75
DNA damage in the oligodendrocyte lineage and its role in brain aging. Mech Ageing Dev (2016) 0.75
Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy. J Alzheimers Dis (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Alzheimer's disease. N Engl J Med (2010) 13.13
Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol (2009) 11.05
Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 9.53
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci (2007) 7.96
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging (2000) 6.47
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science (2001) 6.17
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci (2010) 5.03
The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91
Alzheimer's disease: the challenge of the second century. Sci Transl Med (2011) 4.88
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science (1990) 4.71
Cerebral amyloid angiopathy. A critical review. Stroke (1987) 4.56
Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52
Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science (1987) 3.23
Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A (2011) 3.11
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol (2009) 2.85
A primer of amyloid nomenclature. Amyloid (2007) 2.70
Limbic lesions and the problem of stimulus--reinforcement associations. Exp Neurol (1972) 2.65
Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging (1997) 2.59
The cerebral proteopathies. Neurobiol Aging (2000) 2.29
Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol (2004) 2.21
Amyloid angiopathy-related vascular cognitive impairment. Stroke (2004) 2.21
The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med (2010) 1.86
Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol (1973) 1.85
Dating primate divergences through an integrated analysis of palaeontological and molecular data. Syst Biol (2010) 1.85
Patterns of cognitive decline in aged rhesus monkeys. Behav Brain Res (1997) 1.84
Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J (2010) 1.78
Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol (2007) 1.77
Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol (2004) 1.70
Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol (2010) 1.68
Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol (2004) 1.66
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol (2009) 1.57
Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl (1998) 1.57
Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol (2003) 1.56
The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ (2006) 1.55
An overview of APP processing enzymes and products. Neuromolecular Med (2010) 1.54
Menopause in nonhuman primates? Biol Reprod (2008) 1.52
Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol (2003) 1.52
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J Neurosci (2008) 1.49
Evidence for task-dependent memory dysfunction in the aged monkey. J Neurosci (1989) 1.49
Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am J Pathol (1991) 1.43
Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev (2003) 1.35
Senile plaques in cortex of aged normal monkeys. Brain Res (1985) 1.35
Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis (2010) 1.33
Executive system dysfunction occurs as early as middle-age in the rhesus monkey. Neurobiol Aging (2005) 1.33
Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. Acta Neuropathol (2003) 1.29
On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell Mol Life Sci (2007) 1.29
Executive system dysfunction in the aged monkey: spatial and object reversal learning. Neurobiol Aging (1996) 1.28
Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol (2008) 1.27
Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25
New perspectives on anthropoid origins. Proc Natl Acad Sci U S A (2010) 1.22
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A (1994) 1.22
Impairment in abstraction and set shifting in aged rhesus monkeys. Neurobiol Aging (2002) 1.21
Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction. Neurobiol Aging (1991) 1.20
Amyloid precursor protein in aged nonhuman primates. Proc Natl Acad Sci U S A (1991) 1.19
Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol (2007) 1.17
Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol (1990) 1.17
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol (2006) 1.17
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates. J Pharmacol Exp Ther (2008) 1.16
PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging (2009) 1.15
Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Rev Neurosci (2009) 1.15
Effects of aging on visual recognition memory in the rhesus monkey. Neurobiol Aging (1989) 1.13
Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis (2006) 1.10
Neuropathological diagnostic criteria for Alzheimer's disease. Neuropathology (2004) 1.09
Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol (1990) 1.08
Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease? Genes Brain Behav (2006) 1.07
Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides (2002) 1.07
Tau gene (MAPT) sequence variation among primates. Gene (2004) 1.06
Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus. Neurobiol Aging (1992) 1.05
Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol (1994) 1.05
Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging (2008) 1.05
Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly. Acta Neuropathol (2000) 1.04
MRI description of cerebral atrophy in mouse lemur primates. Neurobiol Aging (2000) 1.04
A beta40 is a major form of beta-amyloid in nonhuman primates. Neurobiol Aging (1997) 1.03
Aging affects executive functions and memory in mouse lemur primates. Exp Gerontol (2006) 1.02
beta-Amyloid (A beta) deposition in the brains of aged orangutans. Neurobiol Aging (1997) 1.02
The development of new therapeutics for Alzheimer's disease. Clin Pharmacol Ther (2010) 1.02
Age differences in recognition memory of the rhesus monkey (Macaca mulatta). Neurobiol Aging (1988) 1.01
Age-associated cerebral atrophy in mouse lemur primates. Neurobiol Aging (2009) 1.00
Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol (2002) 1.00
Effects of small frontal lesions on delayed alternation in monkeys. J Neurophysiol (1957) 0.98
Age-related cerebral atrophy in nonhuman primates predicts cognitive impairments. Neurobiol Aging (2010) 0.97
Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol (2002) 0.96
Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Dis Assoc Disord (1998) 0.96
Senile plaques in aged squirrel monkeys. Neurobiol Aging (1987) 0.96
Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition. Brain Res (2010) 0.94
Naturally occurring and experimentally induced beta-amyloid deposits in the brains of marmosets (Callithrix jacchus). J Neural Transm (Vienna) (2000) 0.94
The aging mind: vascular health in normal cognitive aging. J Am Geriatr Soc (2010) 0.94
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles. Neurobiol Dis (2000) 0.93
Cognitive correlates of white matter growth and stress hormones in female squirrel monkey adults. J Neurosci (2004) 0.93
Animal models of cerebral beta-amyloid angiopathy. Brain Res Brain Res Rev (1997) 0.93
Lack of correlation between plaque burden and cognition in the aged monkey. Acta Neuropathol (1997) 0.93
Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease? Curr Aging Sci (2010) 0.93
Neurotoxicity of β-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis. Curr Pharm Des (2010) 0.93
Targeting tau protein in Alzheimer's disease. Drugs Aging (2010) 0.92
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science (2006) 6.47
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (2010) 3.98
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature (2013) 3.55
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol (2011) 2.94
Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A (2009) 2.27
Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics (2002) 1.75
Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci (2011) 1.66
Research funding. Science funding and short-term economic activity. Science (2014) 1.57
MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol (2007) 1.45
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol (2009) 1.42
The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2004) 1.42
The response of the aged brain to stroke: too much, too soon? Curr Neurovasc Res (2007) 1.39
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol (2010) 1.34
Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol (2008) 1.27
Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J Neurochem (2011) 1.21
Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci Lett (2008) 1.19
PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging (2009) 1.15
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest (2011) 1.10
The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol (2011) 1.06
Molecular polymorphism of Abeta in Alzheimer's disease. Neurobiol Aging (2008) 1.05
Aβ seeds resist inactivation by formaldehyde. Acta Neuropathol (2014) 1.03
Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis. Acta Neuropathol (2012) 0.97
Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci Biobehav Rev (2009) 0.97
Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. J Neurochem (2004) 0.95
Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically. BMC Neurosci (2008) 0.94
Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease. Acta Neuropathol (2006) 0.92
Amyloid by default. Nat Neurosci (2011) 0.91
Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2008) 0.88
Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta). Alzheimer Dis Assoc Disord (2004) 0.86
Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol (2002) 0.85
The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier. Curr Pharm Des (2011) 0.85
SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval. J Vis Exp (2010) 0.85
The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors. Bioorg Med Chem Lett (2008) 0.83
Ovarian aging in squirrel monkeys (Saimiri sciureus). Reproduction (2009) 0.83
Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). Mech Ageing Dev (2004) 0.81
Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI. J Alzheimers Dis (2011) 0.80
Context dependence of protein misfolding and structural strains in neurodegenerative diseases. Biopolymers (2013) 0.80
A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain. J Neurochem (2014) 0.79
The grandmother effect and the uniqueness of the human aging phenotype. Gerontology (2009) 0.79
Proteomic identification of the involvement of the mitochondrial rieske protein in epilepsy. Epilepsia (2005) 0.78
Alzheimer therapeutics-what after the cholinesterase inhibitors? Age Ageing (2006) 0.77
Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? Rom J Morphol Embryol (2008) 0.77
Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys). Comp Med (2013) 0.76
Xanthomatosis. J Neurosurg (2002) 0.75
The Malignant Protein Puzzle. Cerebrum (2016) 0.75